India Crosses 80 Lakh HPV Vaccinations in Major Push Against Cervical Cancer

India has crossed the 80-lakh mark in Human Papillomavirus (HPV) vaccinations, marking a significant milestone in the country’s efforts to strengthen preventive healthcare and protect adolescent girls from HPV-related diseases and cancers. The Union Health Ministry announced the achievement on September 11, describing it as another important step towards building a healthier future for the country’s daughters.

The nationwide HPV vaccination campaign was launched on February 28, 2026, with the objective of protecting girls around the age of 14 from HPV infection and reducing the future burden of cervical cancer. The programme covers girls across all States and Union Territories and provides the vaccine free of cost through government healthcare facilities.

At the outset, Advocate Shivan Raghuwanshi, appearing for UHO, told the bench, also comprising Justices Joymalya Bagchi and V Mohana, that the plea was not against the vaccination programme. | The Indian Express 

Free and Voluntary Vaccination Across India

Under the programme, the single-dose Gardasil-4 vaccine is being provided free of charge at government health facilities, including Ayushman Arogya Mandirs, primary and community health centres, sub-district and district hospitals, and government medical colleges. The campaign was designed to reach approximately 1.2 crore eligible girls aged 14 years across the country.

Vaccination is voluntary and requires parental consent. The government has also put safety mechanisms in place, with trained medical personnel overseeing vaccination sessions and facilities linked to centres capable of managing adverse events following immunisation. Beneficiary information can also be recorded through the U-WIN digital platform, helping strengthen monitoring and tracking of vaccination coverage.

Why HPV Vaccination Is Important

HPV is a common infection, but certain high-risk strains can cause cervical cancer. Vaccination during adolescence is an important preventive measure because it can provide protection before exposure to the virus. The Gardasil-4 vaccine used in the national programme protects against HPV types 16 and 18, which are responsible for a substantial share of cervical cancer cases, as well as types 6 and 11.

India’s campaign is particularly significant because cervical cancer continues to be an important public health concern. Vaccination, however, is only one component of prevention. Screening, early diagnosis and timely treatment remain essential, and the government has stated that its broader strategy combines HPV vaccination with screening and treatment services through the public healthcare system.

Building a Long-Term Prevention Strategy

The scale of the campaign represents a shift towards addressing cervical cancer before it develops rather than relying only on treatment after diagnosis. By making vaccination available through government facilities, the programme also seeks to make preventive protection more accessible to families across urban, rural and underserved areas.

The initial response has shown considerable expansion since the programme began. In July, government data showed that more than 52 lakh girls had already received the vaccine, demonstrating the pace at which the campaign was being implemented nationwide. Crossing 80 lakh vaccinations by September represents further progress towards reaching the programme’s eligible population.

Wider Significance for Women’s Health

The HPV programme also places adolescent health within the larger framework of women’s healthcare. Protecting girls at an early age can help reduce their risk of HPV-associated disease later in life, while stronger awareness of vaccination and screening can encourage families to take preventive healthcare more seriously.

India’s programme also places the country among more than 160 nations that have incorporated HPV vaccination into national immunisation strategies or programmes. Its continued expansion could therefore become an important component of the country’s long-term efforts to reduce cervical cancer.

The MGMM Outlook 

India’s crossing of 80 lakh HPV vaccinations marks a significant step in strengthening preventive healthcare and protecting adolescent girls from HPV-related diseases, including cervical cancer. The nationwide programme, which began in February 2026, provides free, voluntary vaccination to eligible 14-year-old girls through government health facilities across States and Union Territories. The rapid rise from more than 52 lakh vaccinations in July to over 80 lakh by September reflects the expanding reach of the campaign and growing participation in preventive healthcare.

The programme also highlights the importance of combining vaccination with awareness, regular screening, early diagnosis and timely treatment to address cervical cancer comprehensively. By making HPV vaccination widely accessible through the public healthcare system, India is investing in long-term protection for its future generations while strengthening women’s health initiatives. Continued awareness and participation will be essential to ensure that more eligible girls benefit from this nationwide preventive effort.

(Sources: India Today, NDTV, The Indian Express)